euro adhoc: Disclosure announcement after § 15 WpHG
LION Bioscience
AG
Board of Directors (Appointments and Changes)
Supervisory
Board of LION bioscience AG Resigns
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
LION bioscience AG, Cambridge, MA, USA, Heidelberg, Germany, October 14, 2004 LION bioscience (Nasdaq: LEON) today announced that the Supervisory Board of LION bioscience AG, Jürgen Dormann, Prof. Klaus Pohle and Richard Roy stepped down effective immediately after yesterdays Supervisory Board meeting. Due to its NASDAQ listing the company could not extent its Directors & Officers insurance at economically feasible terms.
The local trade court in Heidelberg will appoint the new Supervisory Board. Dr. Friedrich von Bohlen, a major shareholder of the company, has indicated his support for this process.
end of announcement euro adhoc 14.10.2004 09:27:13
Further inquiry note:
Günter Dielmann, Tel.: +49 6221 4038-249,
guenter.dielmann@lionbioscience.com
Julia Fritz, Tel.: +49 6221 4038-158,
julia.fritz@lionbioscience.com
Tracy Coffey, Tel.: +1 857 919 9975,
tracy.coffey@lionbioscience.com
Branche: Pharmaceuticals
ISIN: DE0005043509
WKN: 504350
Index: Nemax 50, Prime Standard
Börsen: Frankfurter Wertpapierbörse / regulated dealing
New York / regulated dealing
Berliner Wertpapierbörse / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Niedersächsische Börse zu Hannover / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade